SPOTLIGHT -
EP. 1: Multidisciplinary Approaches in HCC
EP. 2: Liver Transplant Candidacy in HCC
EP. 3: Resection vs Transplant in HCC: Factors to Consider
EP. 4: Radiofrequency Ablation and Curative Intent in HCC
EP. 5: Locoregional Therapy Options in HCC
EP. 6: HCC: Timing of Locoregional and Systemic Therapies
EP. 7: Dosing Strategies With Sorafenib in HCC
EP. 8: Improving Survival in HCC
EP. 9: Incorporating Regorafenib in the HCC Treatment Landscape
EP. 10: Underlying Cirrhosis in the Second-Line Setting of HCC
EP. 11: Current Understanding With Biomarkers in HCC
EP. 12: Emerging c-MET Inhibitors in HCC
EP. 13: Emerging Multikinase Inhibitors in HCC
EP. 14: Evidence With Checkpoint Inhibition in HCC
EP. 15: The Future of HCC Treatment
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
